{"DataElement":{"publicId":"7643133","version":"1","preferredName":"Ancillary Study KIT Gene Mutation Other Specify","preferredDefinition":"Text different from the ones previously specified which captures the type of molecular genetic abnormality associated with the mutation of the c-kit (CD117) proto-oncogene.","longName":"7643096v1.0:6832577v1.0","context":"OCCPR","contextVersion":"1","DataElementConcept":{"publicId":"7643096","version":"1","preferredName":"Ancillary Study KIT Gene Mutation","preferredDefinition":"A study that is secondary to another study._A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","longName":"7052721v1.0:7643094v1.0","context":"OCCPR","contextVersion":"1","ObjectClass":{"publicId":"7052721","version":"1","preferredName":"Ancillary Study","preferredDefinition":"A study that is secondary to another study.","longName":"C16041","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ancillary Study","conceptCode":"C16041","definition":"A study that is secondary to another study.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"973C983C-51FC-1152-E053-F662850AE6FF","latestVersionIndicator":"Yes","beginDate":"2019-11-13","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-11-13","modifiedBy":"ONEDATA","dateModified":"2019-11-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"7643094","version":"1","preferredName":"KIT Gene Mutation","preferredDefinition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","longName":"C39712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"KIT Gene Mutation","conceptCode":"C39712","definition":"A molecular genetic abnormality that refers to mutation of the c-kit (CD117) proto-oncogene. It is associated with the development of gastrointestinal stromal tumor and gastrointestinal autonomic nerve tumor. It has also been described in acute myeloid leukemias, dysgerminomas, and seminomas.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6779D-D767-4655-E053-4EBD850A3E57","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"ONEDATA","dateModified":"2021-04-27","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6779D-D778-4655-E053-4EBD850A3E57","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":null,"administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6832577","version":"1","preferredName":"Other Specify","preferredDefinition":"Different than the one(s) previously specified or mentioned._Be specific about something; define clearly.","longName":"OTH_SPEC","context":"OCCPR","contextVersion":"1","type":"Non-enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"255","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208051","version":"1","preferredName":"Other Specify","preferredDefinition":"Not otherwise specified.:Specify; be specific about something; define clearly.","longName":"C17649:C25685","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3B5E-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"SBR","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"8E9A3B10-BC5A-67B5-E053-F662850A6556","latestVersionIndicator":"Yes","beginDate":"2019-07-26","endDate":null,"createdBy":"KNABLEJ","dateCreated":"2019-07-26","modifiedBy":"KNABLEJ","dateModified":"2019-08-19","changeDescription":"8/19/19 jk released for reuse by Theradex.  7/26/19 jk created for use on multiple CPTAC CRF questions.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"6601273","version":"1","longName":"CPTAC (Clinical Proteomic Tumor Analysis Consortium)","context":"OCCPR","ClassificationSchemeItems":[{"publicId":"10000348","version":"1","longName":"Melanoma","context":"OCCPR"},{"publicId":"7634324","version":"1","longName":"CM Baseline","context":"OCCPR"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"If other KIT mutation, specif","type":"Preferred Question Text","description":"If other KIT mutation, specify:","url":null,"context":"OCCPR"}],"origin":"CPTAC: Clinical Proteomic Tumor Analysis Consortium","workflowStatus":"RELEASED","registrationStatus":"Application","id":"C0F6783B-326C-54C1-E053-4EBD850AB455","latestVersionIndicator":"Yes","beginDate":"2021-04-27","endDate":null,"createdBy":"SOKKERL","dateCreated":"2021-04-27","modifiedBy":"SOKKERL","dateModified":"2023-09-24","changeDescription":"7/28/21 jk upd sys gen def. 4/27/21 ls created for Phase 3 CM Baseline CRF.","administrativeNotes":"Admin: 9/23/23: Released  melanoma  AI per 3Q23 metric report review. LS","unresolvedIssues":null,"deletedIndicator":"No"}}